FDA: Bayer Hid Negative Study On Surgery Drug
The U.S. Food and Drug Administration said Friday that pharmaceutical company Bayer Pharmaceuticals failed to inform the agency of a study it conducted that showed its heart surgery drug, Trasylol, may...To view the full article, register now.
Already a subscriber? Click here to view full article